The Latest Breaking News from Vaccine

Four UK Chief Medical Officers agreed vaccine deployment should be prioritised where there are localised outbreaks

The HSE says that 6,000 people are at heightened risk from the virus but the initial vaccine rollout will only be offered to 600 people

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

With a strong HPV vaccination programme for girls and a concerted screening and treatment drive for women, the country could be the first in Africa to eliminate the disease

Fainting and fatigue may signal onset of variant, experts say

The auditor-general has examined last year’s vaccine rollout and looked at why it was so slow in aged care and disability care.

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

The U.S. Food and Drug Administration (FDA) has approved Bluebird bio’s (NASDAQ:BLUE) lead asset ZYNTEGLO (betibeglogene autotemcel) to treat the underlying genetic cause of beta‑thalassemia in adult and pediatric patients who require regular red blood cell (RBC) transfusions. Bluebird shares traded in a range of $6.13 to $8.18 on a day…

Academics in Canada looked at data on 85,162 births where half of the mothers had received a coronavirus vaccine during pregnancy.